IL27 and autoimmune disease: In addition, in vivo delivery of recombinant IL-27 by different approaches, including protein infusion pump, as well as lentiviral and adeno-associated virus packaging, have been used to confirm the therapeutic effect of IL-27 in suppressing experimental autoimmune diseases [46,49,58,59].